We are on the cusp of a "breakthrough" in the standard of care for cancer patients. Upon most favorable results we have a delivery method that will prolong and hopefully save lives. Recovery will be less painful, and hence, faster recovery from treatment(s). It will give thousands of people the one thing they are missing, a real fighting chance at survival and a cure!
Add to that the synergistic relationship of the current SOC (heat) and Tdox. Materially the most expensive component is the Heat and that component is already installed and operational. All that the new SOC requires is an intervenous drip of TDOX and a procedural change. Adoption of this new SOC is a no brainer
You highlight one of the critical aspects of this test. If (when) it is successful, it effectively becomes the new SOC for HCC. How huge is that market? I think we are fundamentally underestimating the potential for TDOX.